Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Optimization Of Cancer Treatment Through Overcoming Drug Resistance.

Elshimali YI, Wu Y, Khaddour H, Wu Y, Gradinaru D, Sukhija H, Chung SS, Vadgama JV.

J Cancer Res Oncobiol. 2018;1(2). pii: 107. doi: 10.31021/jcro.20181107. Epub 2018 Feb 27.

2.

The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.

Elshimali YI, Khaddour H, Sarkissyan M, Wu Y, Vadgama JV.

Int J Mol Sci. 2013 Sep 13;14(9):18925-58. doi: 10.3390/ijms140918925. Review.

3.

The clinical significance of circulating tumor cells in the peripheral blood.

Elshimali YI, Grody WW.

Diagn Mol Pathol. 2006 Dec;15(4):187-94. Review.

PMID:
17122646
4.

Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis.

Ngo TH, Barnard RJ, Cohen P, Freedland S, Tran C, deGregorio F, Elshimali YI, Heber D, Aronson WJ.

Clin Cancer Res. 2003 Jul;9(7):2734-43.

5.

Predicting biochemical recurrence after radical prostatectomy for patients with organ-confined disease using p27 expression.

Freedland SJ, de Gregorio F, Sacoolidge JC, Elshimali YI, Csathy GS, Elashoff DA, Reiter RE, Aronson WJ.

Urology. 2003 Jun;61(6):1187-92.

PMID:
12809895
6.

Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy.

Freedland SJ, deGregorio F, Sacoolidge JC, Elshimali YI, Csathy GS, Dorey F, Reiter RE, Aronson WJ.

J Urol. 2003 Apr;169(4):1325-30.

PMID:
12629353

Supplemental Content

Loading ...
Support Center